Jiangsu Hengrui Medicine
600276.SS
#457
Rank
C$76.89 B
Marketcap
C$11.58
Share price
-2.48%
Change (1 day)
15.47%
Change (1 year)
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics

EPS for Jiangsu Hengrui Medicine (600276.SS)

EPS in 2026 (TTM): C$0.20

According to Jiangsu Hengrui Medicine 's latest financial reports the company's current EPS (TTM) is C$0.21. In 2025 the company made an earnings per share (EPS) of C$0.24 an increase over its 2024 EPS that were of C$0.19.

EPS history for Jiangsu Hengrui Medicine from 2000 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C$0.20-15.22%
2025C$0.2424.14%
2024C$0.1942.43%
2023C$0.148.77%
2022C$0.13-20.62%
2021C$0.16-26.59%
2020C$0.2227.24%
2019C$0.1728.41%
2018C$0.1320.04%
2017C$0.1131.21%
2016C$0.0837711.46%
2015C$0.0751536.27%
2014C$0.0551519.77%
2013C$0.0460518.05%
2012C$0.0390123.9%
2011C$0.0314826.9%
2010C$0.0248112.37%
2009C$0.0220856.6%
2008C$0.014109.18%
2007C$0.01291114.48%
2006C$0.00602164.83%
2005C$0.00365335.55%
2004C$0.00269529.73%
2003C$0.00207719.86%
2002C$0.001733-2.71%
2001C$0.0017811.02%
2000C$0.001763